Melanotan 1 10mg
Afamelanotide, [Nle⁴, D-Phe⁷]-α-MSH — 10mg per vial Selective melanocortin receptor agonist (MC1R) Research-grade · Purity verified by HPLC For in vitro research only
For laboratory research use only. Not for human or veterinary consumption. SKU MT1.
Product details.
The selectivity question
This is the distinction that matters against Melanotan 2, which Heritage also carries. MT-1 is the more selective of the two for MC1R, the melanocortin receptor that governs melanin synthesis. MT-2 is less selective and engages MC3R and MC4R as well — which is the basis of its broader and better-known off-target profile. Researchers choose MT-1 when they want the pigmentation pathway isolated from the rest of the melanocortin system.
Specifications
| Sequence | Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂ |
| Also known as | Afamelanotide (INN) |
| Molecular Formula | C78H111N21O19 |
| Molecular Weight | 1646.85 g/mol |
| CAS Number | 75921-69-6 |
| Form | Lyophilized powder |
| Quantity | 10mg per vial |
| Solubility | Soluble in water |
Research areas
MC1R signalling and melanogenesis
Eumelanin synthesis in melanocyte models — the receptor pathway MT-1 was designed to isolate.
Photoprotection models
Investigation of UV response mediated through increased melanin density.
Handling
Reconstitute with bacteriostatic water. Store the lyophilized vial refrigerated and protected from light. Avoid repeated freeze-thaw once in solution.
Research use only
Sold strictly as a research chemical for in vitro laboratory investigation. Not a drug, food, cosmetic or dietary supplement. Not for human or veterinary use.
FDA Disclaimer. All products are for research use only (RUO) as defined by the FDA — not for diagnostic, human, or veterinary use. These products have not been evaluated and have not been approved by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.
Heritage Labs is a chemical supplier providing products strictly for laboratory research, analytical, and in-vitro purposes; it is not a compounding pharmacy or compounding facility under Section 503A, nor an outsourcing facility under Section 503B, of the Federal Food, Drug, and Cosmetic Act.